Sutro Biopharma Inc buy Piper Sandler
Start price
03.04.24
/
50%
€4.78
Target price
03.04.25
€10.16
Performance (%)
-21.34%
Price
17.05.24
€3.64
Summary
This prediction is currently active. The price of Sutro Biopharma Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -21.34%. This prediction currently runs until 03.04.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sutro Biopharma Inc | -8.543% | -8.543% |
iShares Core DAX® | -0.383% | 5.404% |
iShares Nasdaq 100 | 1.248% | 6.732% |
iShares Nikkei 225® | 0.525% | 1.840% |
iShares S&P 500 | 0.640% | 4.710% |
Comments by Piper_Sandler for this prediction
In the thread Sutro Biopharma Inc diskutieren
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $11.00 price target on the stock, down previously from $12.00.
Ratings data for STRO provided by MarketBeat
Stopped prediction by Piper_Sandler for Sutro Biopharma Inc
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€2.28
15.11.23
15.11.23
€11.04
15.11.24
15.11.24
59.65%
17.05.24
17.05.24